These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 9220342

  • 1. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L, Weber PA, Smith JR, Comerford ML, Elliott GT.
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [Abstract] [Full Text] [Related]

  • 2. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A, Maulik N, Elliott GT, Blasig IE, Engelman RM, Das DK.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia.
    Maulik N, Tosaki A, Elliott GT, Maulik G, Das DK.
    Drugs Exp Clin Res; 1998 Jun; 24(3):117-24. PubMed ID: 9825227
    [Abstract] [Full Text] [Related]

  • 5. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
    Shi EY, Jiang XJ, Bai H, Nakajima Y.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):891-5. PubMed ID: 15329271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
    Elliott GT, Comerford ML, Smith JR, Zhao L.
    Cardiovasc Res; 1996 Dec 02; 32(6):1071-80. PubMed ID: 9015409
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
    Imagawa J, Yellon DM, Baxter GF.
    Br J Pharmacol; 1999 Feb 02; 126(3):701-8. PubMed ID: 10188982
    [Abstract] [Full Text] [Related]

  • 9. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury.
    Elliott GT.
    J Mol Cell Cardiol; 1998 Jan 02; 30(1):3-17. PubMed ID: 9500877
    [Abstract] [Full Text] [Related]

  • 10. Delayed endothelial protective effects of monophosphoryl lipid A after myocardial ischemia and reperfusion in rats.
    Richard V, Danielou E, Kaeffer N, Thuillez C.
    J Mol Cell Cardiol; 1999 May 02; 31(5):1117-23. PubMed ID: 10336849
    [Abstract] [Full Text] [Related]

  • 11. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.
    Yoshida T, Engelman RM, Engelman DT, Rousou JA, Maulik N, Sato M, Elliott GT, Das DK.
    Ann Thorac Surg; 2000 Sep 02; 70(3):895-900. PubMed ID: 11016330
    [Abstract] [Full Text] [Related]

  • 12. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning.
    Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV.
    J Mol Cell Cardiol; 2000 Jul 02; 32(7):1159-67. PubMed ID: 10860760
    [Abstract] [Full Text] [Related]

  • 13. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
    Yao Z, Rasmussen JL, Hirt JL, Mei DA, Pieper GM, Gross GJ.
    J Cardiovasc Pharmacol; 1993 Oct 02; 22(4):653-63. PubMed ID: 7505370
    [Abstract] [Full Text] [Related]

  • 14. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW, Taft CS, Ramnauth S, Zhao ZQ, Vinten-Johansen J.
    Cardiovasc Res; 1995 Jul 02; 30(1):79-86. PubMed ID: 7553727
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog.
    Yao Z, Auchampach JA, Pieper GM, Gross GJ.
    Cardiovasc Res; 1993 May 02; 27(5):832-8. PubMed ID: 8394211
    [Abstract] [Full Text] [Related]

  • 16. Second window of protection against infarction in conscious rabbits: real or artifactual.
    Miki T, Swafford AN, Cohen MV, Downey JM.
    J Mol Cell Cardiol; 1999 Apr 02; 31(4):809-16. PubMed ID: 10329208
    [Abstract] [Full Text] [Related]

  • 17. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH, Chen ZW, Wu Z.
    Can J Physiol Pharmacol; 2008 Mar 02; 86(3):131-8. PubMed ID: 18418440
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
    Sharony R, Frolkis I, Froylich D, Wildhirt SM, Shapira I, Reichart B, Nesher N, Uretzky G.
    Eur J Cardiothorac Surg; 2005 Mar 02; 27(3):501-7. PubMed ID: 15740963
    [Abstract] [Full Text] [Related]

  • 19. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B, Sarkar C.
    J Cardiovasc Pharmacol; 2006 Feb 02; 47(2):277-86. PubMed ID: 16495767
    [Abstract] [Full Text] [Related]

  • 20. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction.
    Xi L, Kukreja RC.
    Toxicology; 2000 Nov 30; 155(1-3):37-44. PubMed ID: 11154795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.